


Ask a doctor about a prescription for DALSYDOL 400 MG ORAL SUSPENSION
Leaflet: information for the user
Dalsydol 400 mg oral suspension
ibuprofen
Read this leaflet carefully before starting to take this medicine, as it contains important information for you
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor, pharmacist, or nurse.
Contents of the leaflet
Ibuprofen, the active ingredient of this medicine, acts by reducing pain and fever.
This medicine is used in adults and adolescents from 12 years old and weighing more than 40 kg for the symptomatic relief of occasional mild or moderate pain, such as headaches, dental, menstrual, muscular (cramps), or back pain (lumbago), as well as in febrile states.
Do not take Dalsydol:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Tell your doctor:
Infections
Ibuprofen may hide the signs of an infection, such as fever and pain. Consequently, ibuprofen may delay the appropriate treatment of the infection, which can increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the infection symptoms persist or worsen, consult a doctor without delay.
Cardiovascular precautions
Anti-inflammatory/analgesic medicines like ibuprofen may be associated with a small increased risk of having a heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration. You should discuss your treatment with your doctor or pharmacist before taking this medicine if:
Similarly, this type of medicine may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Skin reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue Dalsydol treatment and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Children and adolescents
There is a risk of kidney damage in dehydrated children and adolescents.
Taking Dalsydol with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine, including those obtained without a prescription.
The following medicines may interfere and should not be taken with ibuprofen without consulting your doctor:
Other medicines may also affect or be affected by ibuprofen treatment. Therefore, you should always consult your doctor or pharmacist before using ibuprofen with other medicines.
Interference with analytical tests
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are taking this medicine, as it may alter the results.
Taking Dalsydol with food, drinks, and alcohol
You can take it alone or with food. In general, it is recommended to take it with meals to reduce the possibility of stomach discomfort.
If you drink alcohol while taking this medicine, you may be more prone to side effects.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not take ibuprofen if you are in the last 3 months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected. You should not take ibuprofen during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, Dalsydol may cause kidney problems in your fetus if taken for more than a few days, which can cause low levels of amniotic fluid surrounding the baby (oligohydramnios). If you need treatment for more than a few days, your doctor may recommend additional checks.
Precautions during pregnancy and in women of childbearing age
Pregnancy
Due to the administration of medicines of this type being associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy, unless it is considered strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of this medicine is contraindicated.
Fertility
For patients of childbearing age, it should be taken into account that medicines like ibuprofen have been associated with a decrease in fertility.
Breastfeeding
Although the levels of the medicine in breast milk are negligible, it is recommended to consult a doctor in cases of long-term treatment or high doses during breastfeeding.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, you should not drive or operate machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Dalsydol contains sodium, sodium benzoate (E-211), and liquid maltitol (E-965)
This medicine contains 57.94 mg of sodium (main component of table salt/cooking salt) per sachet. This is equivalent to 2.9% of the maximum recommended daily sodium intake for an adult.
Patients on low-sodium diets should note that this medicine contains 57.94 mg (2.5 mmol) of sodium per sachet.
This medicine contains 10 mg of sodium benzoate (E-211) per sachet. Sodium benzoate may increase the risk of jaundice (yellowish skin and eye color) in newborns (up to 4 weeks old).
This medicine contains liquid maltitol (E-965). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Follow the administration instructions of the medicine contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
It is essential to always take the smallest dose that relieves the pain and not to take the medicine for longer than necessary to control your symptoms.
The effective lowest dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Dosage
Adults and adolescents (over 40 kg in weight) from 12 years:
The recommended dose is one sachet (400 mg of ibuprofen every 4-8 hours), depending on the intensity of the symptoms and the response to treatment. No more than 3 sachets (1200 mg) should be taken within 24 hours.
Elderly patients:
The dosage should be established by the doctor, as it may be necessary to reduce the usual dose. Elderly people are often more prone to adverse effects.
Patients with kidney, liver, or heart disease:
Reduce the dose and consult a doctor. Ibuprofen should not be used in patients with severe renal, hepatic, or cardiac insufficiency.
If symptoms worsen, if fever persists for more than 3 days or pain for more than 5 days (3 days in adolescents), you should consult a doctor.
The administration of this medicine is subject to the appearance of pain or fever. As these disappear, the medication should be suspended.
Use in children and adolescents:
The use of this medicine is not recommended in children or adolescents with a weight of less than 40 kg.
Method of administration
This medicine is a suspension, administered orally.
It is necessary to homogenize the suspension immediately before taking it, as indicated in the following figure:

1 – Press the top and bottom of the sachet with your fingers several times.
2 – Press from top to bottom and vice versa for at least 30 seconds.
It can be taken directly from the sachet or diluted in water.
In case of digestive discomfort, it is recommended to take the medicine with meals.
If you take more Dalsydol than you should
If you have taken more oral suspension than you should or have accidentally ingested the contents of the package, consult your doctor or pharmacist or the Toxicology Information Service, phone: 91 5620420, indicating the medicine and the amount ingested. It is recommended to bring the package and the prospectus of the medicine to the healthcare professional.
If you have taken more Dalsydol than you should, or if a child has accidentally ingested the medicine, consult a doctor or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Overdose symptoms may include nausea, stomach pain, vomiting (which may contain bloody sputum), headache, ringing in the ears, confusion, and involuntary eye movement. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties have been reported.
It is rare for more severe symptoms to appear, such as intestinal bleeding, low blood pressure, low body temperature, metabolic acidosis, convulsions, altered kidney function, coma, adult respiratory distress, and transient respiratory arrest in children (after ingesting large amounts).
If a severe poisoning has occurred, the doctor will take the necessary measures.
If you forget to take Dalsydol
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at the usual time.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
The frequencies shown below refer to the short-term use of maximum daily doses of up to 1200 mg of oral ibuprofen:
disorientation or confusion, depression, vertigo, tinnitus (ringing or buzzing in the ears), reversible toxic amblyopia, liver damage, edema (swelling caused by fluid accumulation in tissues), optic neuritis.
Exacerbation of inflammation-related infections has been observed coinciding with the use of NSAIDs. If signs of infection or worsening of symptoms occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
exacerbation of colitis and Crohn's disease (chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces bloody diarrhea).
A severe skin reaction known as DRESS syndrome may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell). Generalized red scaly rash, with bumps under the skin and blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis).
Stop taking Dalsydol if you experience these symptoms and seek medical attention immediately. See also section 2.
The skin becomes sensitive to light.
If any of the following adverse effects occur, discontinue treatment and consult your doctor immediately:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines, www.notificaRAM.es.
Keep this medicine out of sight and reach of children.
Store below 30°C.
Do not use this medicine after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE collection point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Dalsydol
Appearance of the product and package contents
Dalsydol is a white, strawberry-flavored oral suspension contained in elongated monodose sachets (sticks) of 10 ml, formed by a complex of polyester, aluminum, polyester, and polyethylene.
It is presented in packages of 12 or 20 units (sticks).
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
ALCALA FARMA, S.L.
Avenida de Madrid, 82
28802 Alcalá de Henares (Madrid)
“or”
ZINEREO PHARMA, S.L.U.
A Relva, s/n, O Porriño,
36410 Pontevedra
“or”
FARMALIDER, S.A.
C/Aragoneses, 2
28108 Alcobendas (Madrid)
“or”
EDEFARM S.L.
Polígono Industrial Enchilagar del Rullo, 117
46191 Villamarchante (Valencia)
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
Date of the last revision of this prospectus: October 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DALSYDOL 400 MG ORAL SUSPENSION – subject to medical assessment and local rules.